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1. Introduction 
 
The goal of radiation therapy is to kill tumor cells while reducing the injury to the 
normal tissues. The physician prescribe the target dose based on the experience 
gained over several years through research on the radiation dose that is adequate 
for the control of the particular tumor type, while the physicists ensure that the 
prescribed dose is delivered to the target with a great degree of accuracy. While 
small deviations from the prescribed dose may be acceptable, large deviations are 
not since this can result in either poor tumor control or increase the possibility of 
the adverse effects of radiation.  Source of error in delivering the prescribed dose 
to the target include error in the positioning of patient and the errors due to the 
uncertainty of calculated dose. The primary method of delivering the radiation 
dose to the target volume with external beam radiation therapy is with the use of 
linear accelerators. The dose that will be achieved in the target from a linear 
accelerator is often calculated and verified afterwards through measurements 
before the planned treatment is delivered to the patient. As would be expected, 
there are always some errors which exist between the calculated dose and the 
measured dose. The aim however, is to keep such discrepancies to a minimum, and 
the analysis of discrepancies between the calculated and measured dose is 
necessary in order to implement programs aimed at reducing such errors.      
The desirable characteristics of dose calculation methods in radiation therapy are 
that the calculation be fast enough so that the treatment planning process can be 
completed in a clinically acceptable time frame; and secondly that the result of the 
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dose calculation be sufficiently accurate (Oelfke and Scholz, 2006). Intensity 
modulated radiation therapy is considered as the state of the art method of 
achieving greater tumor control with a minimum of normal tissue injury. The 
intensity-modulated fields are used to deliver highly conformal dose distributions 
in radiotherapy, which leads to better sparing of the normal tissue. Intensity 
modulated fields delivered with multi-leaf collimators are routinely used in the 
treatment of prostate and head and neck cancers and the verification of the dose 
distribution with this method of radiotherapy treatment poses new challenges for 
quality assurance (Jenghwa Chang et al., 2000).  Some authors have reported 
discrepancies between calculated and measured dose of greater than 5 percent 
while other authors have reported even higher values in excess of 10 percent. The 
uncertainty in the dose calculated by a conventional dose calculation algorithm has 
been reported to be between 5 to 10 percent in the presence of heterogeneities. 
Similar error values were also reported for dose calculated using Monte Carlo 
methods (Ma et al., 2000). 
Medical physicists strive to achieve an accuracy of better than 5 percent during the 
course of delivering the prescribed target dose. This objective can only be achieved 
if the dose calculation accuracy is better than 2 percent (Fippel, 2006), since there 
are other contributing sources of dose delivery errors such as patient positioning, 
motion, etc. As stated by Oekfke and Scholz in their work (Oelfke and Scholz, 
2006), the calculation of distribution within the patient form the only reliable and 
verifiable link between the chosen treatment parameters and the observed clinical 
outcome for a specified treatment technique. It is thus necessary that the dose 
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calculation method be accurate. The accuracy can only be quantified comparing 
the calculated dose with the measured dose. There are many methods of dose 
calculations. It is the objective of this research work to investigate the accuracy of 
one of such methods of patient dose calculation, which is gradually being 
introduced for clinical dose calculation. 
1.1 Dose calculation methods  
 
The purpose of dose calculation is to predict the dose at any point in a given 
medium using information of the makeup of the medium and the dose delivery 
device. In radiation therapy treatment planning, the dose distribution in a patient 
for any given beam set up is first calculated/predicted before the treatment is 
delivered. Computerized tomography images of the patient are usually used to 
provide information on the material makeup of the patient, and hence the 
interactions of the treatment beams in the patient, while measurements made in a 
water phantom usually provide the information used to model the beam delivery 
device and the quality of the beam. The physician prescribes the dose necessary to 
control the tumor based on prior experience on the dose which is adequate to 
control the tumor, it is thus important that the calculated dose distribution be 
accurate to a high degree, since large deviations may result in adverse effects. 
Evidence suggests that dose difference of about 7 percent is clinically evident and 
researchers have also shown that a 5 percent dose difference can result in 10 – 20 
percent changes in tumor control probability or up to 20 - 30 percent changes in 
normal tissue complication probabilities (Indrin et. al., 2007). Another important 
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desirable feature of any dose computation method for clinical use is that the 
computation method be fast enough to be clinically feasible. A wide range of 
methods for computing dose exists with varying degrees of complexities and no 
general classification consensus (Rosenwald, 2007); however, some authors  has 
classified dose computation as either ‘indirect/correction based' or ‘direct/ model 
based' dose calculation methods (Podgorsak, 2005, Fippel, 2006)).  The dose 
calculated by any of these methods is often verified experimentally through 
measurements before the treatment is delivered (Podgorsak, 2005). 
 
1.1.1 Indirect/ correction based dose computation method 
 
This method of dose computation was the first to be developed (Oelfke and Scholz, 
2006). The indirect first methods measure the physical characteristics of the 
radiation beam such as depth dose, tissue-air ratio, output factors, tissue phantom 
ratios, etc. in a homogenous water phantom. To calculate the dose distribution in a 
patient, the dose measurements made in the water phantom are extrapolated and 
adapted to the patient by correcting for the differences between the makeup of the 
water phantom and the patient. The corrections that are necessary to adapt or 
convert the dose distribution in the phantom to that of the patient include 
corrections for tissue inhomogeneities, since some irradiated tissues in the patient 
such as the bones and lung have different electron densities that are considerably 
different from the homogenous electron density of the water phantom; correction 
for beam modifiers that may be required for the treatment of the patient and 
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corrections for irregular patient surface (Mackie et al., 2007, Podgorsak, 2005). 
The correction based methods have the advantage of being fast (Oelfke and Scholz, 
2006), the accuracy of this method is however low in the presence of 
inhomogeneities. 
 
1.1.2 Direct / model based dose computation methods 
 
The direct method of dose computation is a more complex method of predicting 
the dose distribution within a patient. Unlike the indirect method which measures 
dose distribution from the beam in a water phantom and then adapt the 
measurement to the desired medium (the patient), the direct dose computation 
methods model the interaction and deposition of energy by the beam as it 
transverses the patient. Although direct method also requires that measurement 
be made in a phantom, they are used to set the parameters for the model and for 
verification. This method of dose computation is computationally more expensive 
relative to the indirect method, however they are more accurate. The model based 
methods include the pencil beam, collapsed cone and Monte Carlo dose 
computation methods (Fippel, 2006). The pencil beam is the simplest while the 
Monte Carlo method is the most complex. A rule of thumb in the dose calculation 
methods is that the simpler methods are often the fastest while the more complex 
methods are the most accurate. The method of interest in this work is the Monte 
Carlo method of dose computation, which will be discussed in better details. 
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1.2 Monte Carlo dose calculation 
The Monte Carlo method is the most complex of the dose calculation methods and 
also the most accurate and thus has a clear preference relative to other dose 
calculation methods in the quest for a dose delivery accuracy of 5 percent or better 
(Fippel, 2006).  Research has shown Monte Carlo dose calculation to be 
particularly accurate in a heterogeneous medium clinically represented by the 
patient, where other dose calculation methods yield poor results due to failure to 
accurately model electron transport in such medium and various levels of 
approximations they employ. This method has however until recently been 
considered impractical for clinical patient dose calculation due to the often long 
calculation time required. However, the development of faster computers and 
Monte Carlo codes has lead to Monte Carlo codes being increasingly clinically 
available for patient dose calculation. The Monte Carlo method of dose calculation 
simulates the transport and interactions of photons and electrons as they traverse 
through a medium by using current physical knowledge of the probability of 
interactions of individual photons and electrons as they traverse the medium of 
interest. The kind of interactions simulated for radiation therapy includes 
photoelectric absorption, Raleigh scattering, Compton scattering and pair 
production. The macroscopic features (physical manifestation of interactions) of 
the radiation beam are computed as an average of many simulated interactions of 
particles or histories. If the true average of the particles’ interactions exists and the 
individual particle interactions has a variance of     from the average value, then 
the Central limit theorem stipulates that that the estimate of the average 
7 
 
interactions gets closer to the true value as the number of simulated particle 
histories/ interactions is increased. The theorem also predicts that as the number 
of simulated histories tends to infinity, the statistical variance tends to zero.  The 
number of simulated particles (histories),  , that has to be directed toward a 
target volume in a Monte Carlo simulation is approximately given by: 
   
 
     
                          
Where   is the exposed beam area,   is the percent relative error (deviation) being 
sought,   is the attenuation coefficient, and    is a typical voxel dimension. Thus 
for a given field dimension and medium of given attenuation coefficient, the 
relationship between voxel size and number of particle histories is inverse. The 
greater the number of histories, the smaller is the uncertainty (Mackie et al., 2007, 
Nahum, A, 2007, Bielajew, A, 2007, Fippel, 2006).   
 
The efficiency,  , of Monte Carlo dose calculation is expressed  as  
  
 
   
                                             
With   and   as the estimate of the variance and computation time required to 
obtain the variance respectively. There are two ways in which the efficiency of a 
given Monte Carlo dose calculation dose calculation can be improved: either 
decrease      (variance) for a given computation time or decrease    (computation 
time) for a given particle history while not changing the variance. Techniques 
which improve the efficiency of the dose calculation by changing the variance for a 
given particle history while not biasing the results are known as variance 
reduction techniques. Widely used variance reduction techniques include 
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Bremsstrahlung splitting and Russian roulette. (Indrin et. al., 2007, Kawrakow & 
Fippel, 2000) 
 
1.3 Beam measurement and verification 
Measurement of the calculated dose can be done using ionization chambers, 
thermoluminescent devices (TLDs), radiochromic or radiographic films, or 
electronic portal imaging devices (EPIDs) together with specially designed 
verification phantoms.  The measured dose is compared to the calculated dose 
using verification software. There are many commercially available software that 
can be used to compare the computed and measured dose distributions. The 
verification software read in the calculated dose from the treatment planning 
system and that measured using the measuring device and then analyze both data 
sets for agreements and quantify the error therein. Standard evaluation tools are 
the overlay of both  isodoses and profiles of the dose data (Rhein and Haring, 
2006). 
 
The gamma index is a mathematical tool that enables two dose distributions to be 
quantitatively compared for similarity and is widely used in IMRT verification 
software tools  that was proposed by Low (Rhein and Haring, 2006, Hrbacek et. al., 
2007).  According to an article cited in the work by Hrbacek et. al. (Hrbacek et. al., 
2007), when gamma evaluation is being performed, one dose distribution is 
referred to as the reference while the other is referred to as the evaluated.  The 
gamma index is computed for each point of the reference dose distribution using 
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the entire evaluated dose distribution. The work further stated that the gamma 
evaluation is not symmetric with two dose distributions and that care should be 
taken on the dose distribution to be used as a reference as it could have influence 
the gamma evaluation result. 
 
 
Figure 1: Screenshot of a dose comparison program. 
The two images to the left are the measured and calculated doses; the right upper 
plot contains the profile of the doses while the right lower plot is the gamma 
comparison image. Red highlights region of disagreement between the two 
dataset. Source:  OmniPro I’mRT documentation 
 
 
The gamma index is calculated based on a dose difference and distance to 
agreement criteria and the measured dose data is usually used as the reference. 
The gamma value,  , for the measurement point    is defined as 
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Where 
          √
         
    
 
         
    
                               
          |      | 
and  
                                              
 
Where     is the dose calculated for a given point,     is the dose measured for the 
calculated point which is often taken as the reference dose,      is the defined 
passing distance between isodose points (the calculated and the measured),     
is the dose difference value between the calculated and measured which is 
accepted as pass. For each point in the evaluated data points, the gamma is 
computed as specified by equation 1.3 and the evaluation is scored. This scoring 
could be said to be Boolean and is specified as 
 
      {
     
     
 
 
Where 1 and 0 specifies passed and failed evaluation points respectively. The 
gamma calculation is performed for all    (Low et al., 1998, Rhein and Haring, 
2006). In other words, if the dose calculated and that measured does not agree 
based on the defined evaluation criteria (distance to agreement and acceptable 
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dose difference values), the calculation for that point fails and vice versa. The 
result of gamma analysis is usually presented in terms of the percentage 
agreement between calculated and measured points. Hrbacek et. al. reported very 
good gamma evaluation results using the OmniPro I'mRT® software in their work 
(Hrbacek et. al., 2007), which shows that even at a stringent gamma evaluation 
criteria of 1 mm and 1 % for the distance to agreement and dose difference values 
respectively,  that 70 % of the evaluated profiles had gamma values of less than or 
equal to one. 
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2. Materials and methods 
2.1 Dose calculation and delivery 
 
Calculation for dose distribution was made using Monaco treatment planning 
system (Elekta, Monaco Version 2.03.00).  The algorithm employs Monte Carlo 
simulation for dose computation. Multiple calculations were made using variances 
(dose calculation uncertainty) of 0.5, 1, 2, 3, 5 and 10%. The Monaco® training 
guide recommends using variance ranging from 1 – 3% although the full available 
variance treatment planning system ranges from 0.5% - 10%.  Calculations were 
made for various regular square and rectangular open fields, irregular shaped 
fields and IMRT clinical cases. The calculation times at different variances for some 
field shapes and sizes were recorded and analyzed. 
 The calculated dose was exported to the control software of the linear accelerator, 
Mosaiq®, and ultimately to the accelerator itself. The linear accelerator is an 
Elekta Synergy (Elekta Oncology Systems Ltd, Sweden). A beam energy of 6 MeV 
was used for calculation and the same beam energy was used for the exposure of 
the dosimetric film.  The films used are GAFCHROMIC EBT2 dosimetric films that 
were exposed in a homogenous solid water phantom. The phantom has 29 slabs 
each of dimension 30 X 30 X 1 cm and the films were exposed at a chosen depth 
corresponding to that specified when the treatment plan was exported from the 
treatment planning system to the machine. 100 cm SSD was used for the film 
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exposure. Figures 1 and 2 show the linear accelerator and the solid water phantom 
used for the dosimetric studies respectively. 
 
 
Figure 2: An Elekta Synergy linear accelerator 
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2.2 Film calibration, comparison of calculated and measured dose 
 
Prior to exposing the dosimetric films, the films were carefully labeled for proper 
identification and scanned using EPSON Expression® 10000 XL Photo Scanner and 
the pre-exposed film images were  saved.   
 
 
Figure 3: The solid water phantom used for film exposure 
 
The films were exposed in the homogenous water phantom and subsequently 
processed. The processed films, which contain the measured dosimetric 
information were scanned using the same scanner settings and format as was used 
for the scanning of the pre-exposed film. The scanning set up employed also 
ensured that the pre-exposed and exposed films were scanned using the same 
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orientations. The difference between the pre-exposed and exposed film was 
subtracted using an algorithm to give the true value of the optical density – the 
correct measured dose. The subtraction is necessary because the full optical 
density of the exposed film also include background density due to film fog and the 
density of the film materials, such as the film base and emulsion layer. An 
algorithm was used to convert the measured optical density to dose values. The 
calculated dose was compared with the measured dose using OmniPro I'mRT® 
software. The software employs the Gamma evaluation method described in 
earlier section. Four dose difference (DD) and distance-to-agreement (DTA) values 
were used for the comparison. The values used are 5 % and 5 mm, 4 % and 3 mm, 
3 % and 3mm, and 2 % and 2 mm for the DD and DTA pairs respectively. 
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3. Result 
3.1 Gamma analysis and computation time 
 
Figure 4 shows the calculated dose distribution for square fields of 10 cm2 using 
variances of 0.5, 1, 2, 3, 5 and 10%. At low variances, the calculated dose 
distribution appears smooth with little noise, whereas at higher variances, the 
distribution appears to contain a lot of noise which appears as increase in the 
graininess of the image as the variance increases. 
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(A) variance 0.5% 
 
(B) variance 1% 
 
(C) variance 2% 
 
(D) variance 3% 
 
(E) variance 5% 
 
(F) variance 10% 
 
Figure 4: Calculated dose distribution 
The figure shows 6 images shows the dose distribution calculated for a square field 
using different variance. Note how the graininess (noise) in the images increases 
with increasing variance. 
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Figure 5 shows the profile of the calculated and the measured dose distribution at 
different variances for a square 10 x 10 cm field. The red plots in the figures 
represent the profile of the measured dose while the green ones show the profile 
of the calculated dose.  At low variances, the measured and calculated dose 
distributions are mostly similar, whereas at higher variances, the noise in the 
calculated dose is increased, evident as the spikes present in the profile. 
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(A) variance 0.5% 
 
(B) variance 1% 
 
(C) variance 2% 
 
(D) variance 3% 
 
(E) variance 5 
 
(F) variance 10 
 
Figure 5: Profile of calculated and measured dose distribution 
Note how the noise which is evident as the spikes in the calculated dose 
distribution increases with increasing variance. 
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Figure 6 show the gamma evaluation results for dose calculated using different 
variance. The gamma comparison was made with DD and DTA of 4 % and 3 mm 
respectively. The values of the variance used in calculating the dose are included in 
the figure. It can be seen that the gamma result decreases (grainy red regions) as 
the variance (uncertainty in calculation) increases due to increasing disagreement 
of the data pairs as the variance is increased.  
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(A) variance 0.5%- gamma result = 99.90%  
 
 (B) variance 1%-gamma result = 99.86% 
 
(C) variance 2%- gamma result = 99.72% 
 
 (D) variance 3%- gamma result = 98.62% 
 
  (E) variance 5- gamma result = 93.50% 
 
  (F) variance 10- gamma result = 82.16 % 
 
Figure 6: Gamma evaluation result 
The gamma evaluation result for the square field shows the decrease in agreement 
between the calculated and measured dose distribution as the variance is 
increased. 
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Table 1 shows the field sizes, approximate shape, irradiation parameters (depth, 
monitor units (MU)), variances, gamma evaluation criteria and results for square 
fields. For all the fields, variances of 0.5, 1, 2, 3 and 5% were used in calculating the 
dose distribution while DD and DTA value pairs of 5 % and 5 mm, 4% and 3 mm, 3 
% and 3 mm and 2 % and 2 mm were chosen as the pass criteria and used for 
evaluations. Gamma scores of 95 – 100% are considered as having passed the 
evaluation whereas lower scores are considered as a failure of agreement between 
the computed and measured dose distribution. It can be seen that at DD and DTA 
of 5 % and 5 mm respectively, nearly all the gamma evaluation have results of 100 
% and only the evaluation result for the 15 X 15 field made with a variance of 5% 
failed the gamma evaluation at the stated DD and DTA values. It can also be seen 
that generally, the passed results generally reduce as the field size increases. For 
instance, at DD and DTA of 3 % and 3 mm and field sizes of 1.1 cm2 to 3 cm2 except 
for the calculated dose made with a variance of 5%, all gamma evaluation results 
exceeded the pass value. However, at larger field sizes, the failed points increase. 
At low variance up until the 3% recommended and gamma criteria   3 % and 3 
mm for the DD and DTA respectively, almost all the calculated dose agrees with the 
measured dose, however at higher variance values, the level of agreement is 
reduced. 
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Table 1 shows the gamma evaluation result for the square fields studied. 
Field Size 
W cm x L cm 
The Shape 
Depth 
(cm) 
MU 
Variance 
(%) 
The Result Of Gamma Index 
Dose Comparison Tools: 
The Dose Difference (DD) 
& 
The Distance-To-Agreement (DTA) 
DD 5% 4% 3% 2% 
DTA 5mm 3mm 3mm 2mm 
1.1 x 1.1 
 
5 250 
0.5 100% 100% 100% 100% 
1 100% 100% 100% 100% 
2 100% 100% 100% 100% 
3 100% 100% 100% 100% 
5 100% 100% 100% 100% 
2 x 2 
 
5 250 
0.5 100% 100% 100% 100% 
1 100% 100% 100% 100% 
2 100% 99.17% 98.15% 93.87% 
3 100% 98.27% 97.15% 91.71% 
5 100% 98.00% 97.00% 89.60% 
3 x 3 
 
5 250 
0.5 100% 99.71% 98.65% 94.59% 
1 100% 99.70% 98.83% 93.94% 
2 100% 99.93% 98.61% 92.62% 
3 100% 99.57% 98.01% 88.94% 
5 98.75% 96.71% 94.41% 86.65% 
5 x 5 
 
5 250 
0.5 100% 100% 99.66% 91.69% 
1 100% 99.58% 97.94% 88.02% 
2 99.92% 97.29% 94.12% 81.67% 
3 99.50% 96.50% 92.88% 78.16% 
5 97.93% 93.22% 89.17% 77.25% 
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10 x 10 
 
10 250 
0.5 100% 99.91% 99.54% 98.64% 
1 100% 99.87% 99.49% 98.20% 
2 99.98% 99.77% 99.26% 95.92% 
3 99.84% 98.84% 97.38% 91.89% 
5 98.32% 95.43% 92.82% 82.53% 
10 82.16% 72.07% 65.95 52.59% 
15 x 15 
 
4 250 
0.5 99.98% 99.34% 97.50% 84.06% 
1 99.97% 98.95% 96.43% 82.94% 
2 99.72% 97.23% 93.32% 80.61% 
3 98.61% 94.42% 89.62% 77.96% 
5 94.34% 86.04% 80.96% 69.17% 
20 x 20 
Half Field  
2 200 
0.5 99.90% 99.40% 98.09% 91.18% 
1 99.88% 99.28% 97.78% 90.34% 
2 99.76% 98.36% 96.00% 87.45% 
3 99.09% 96.54% 93.21% 83.76% 
5 96.33% 91.67% 86.55% 75.56% 
 
Table 2 shows the results for the rectangular fields. For the 10 X 2 cm and 15 X 5 
cm fields, note that two measurements were made with the films oriented 
horizontally and vertically relative to the positions of the MLCs and the interesting 
pattern of the comparison results observed for the two types of orientations. The 
gamma results for the 2 X 10 cm films are generally better than the results for the 
10 X 2 cm film, whereas the results for the 15 X 5 cm films are generally better 
than the results for the 5 X 15 cm film.  
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Table 2 shows the gamma result for rectangular fields 
Field Size 
W cm x L cm 
The Shape 
Depth 
(cm) 
MU 
Variance 
(%) 
The Result Of Gamma Index 
Dose Comparison Tools: 
The Dose Difference (DD) (%) 
& 
The Distance-To-Agreement(DTA) (mm) 
DD 5% 4% 3% 2% 
DTA 5 mm 3 mm 3 mm 2 mm 
0.6 x 1.1 
Smallest 
Field in 
Monaco 
 
5 250 
0.5 100% 100% 100% 100% 
1 100% 100% 100% 100% 
2 100% 100% 100% 100% 
3 100% 100% 100% 100% 
5 100% 100% 100% 100% 
10 x 2  5 250 
0.5 100% 97.55% 94.16% 76.95% 
1 99.97% 97.17% 94.05% 76.35% 
2 99.92% 95.51% 91.30% 71.98% 
3 99.80% 95.18% 89.87% 70.77% 
5 98.40% 90.38% 86.62% 69.57% 
2 x 10  5 250 
0.5 100% 99.60% 98.81% 89.74% 
1 100% 99.58% 98.74% 89.30% 
2 99.94% 98.94% 97.10% 87.93% 
3 99.51% 97.94% 96.27% 87.77% 
5 99.48% 97.61% 96.15% 87.20% 
15 x 5 
 
5 250 
0.5 99.85% 96.55% 91.59% 74.31% 
1 99.62% 96.39% 91.18% 74.00% 
2 99.01% 94.60% 89.07% 72.41% 
3 98.01% 91.87% 86.67% 71.31% 
5 93.58% 85.89% 80.38% 64.19% 
5 x 15 
 
5 250 
0.5 99.57% 90.49% 78.35% 53.57% 
1 98.67% 89.24% 78.08% 52.66% 
2 96.67% 85.03% 75.68% 56.69% 
3 94.48% 82.79% 74.99% 54.63% 
5 88.04% 76.48% 70.88% 57.51% 
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Table 3 shows the gamma evaluation results for irregular fields obtained at 
various dose difference (DD) and distance to agreement (DTA) values. As should 
be expected, it can be seen that as the variance increases, the gamma evaluation 
result (proportion of pass) decreases. At DD and DTA of 3 % and 3 mm 
respectively, almost all dose calculation made with variance of less than 5 % 
passed the gamma evaluation, whereas most of the calculation made with 
variances equal to or higher than this value mostly failed (gamma ≤ 95%) .   
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Table 3 shows the field shape, exposure parameters, gamma criteria and 
results for irregular fields 
The Field 
 
The 
Shape 
 
Depth 
(cm) 
MU 
 
Variance 
(%) 
The Result Of Gamma Index 
Dose Comparison Tools: 
The Dose Difference (DD) (%) 
& 
The Distance-To-Agreement(DTA) (mm) 
DD 5% 4% 3% 2% 
DTA 5mm 3mm 3mm 2mm 
Letter L 
 
5 250 
0.5 100% 99.37% 98.54% 90.84% 
1 100% 99.21% 98.23% 90.38% 
2 100% 98.89% 98.01% 89.84% 
3 99.52% 97.75% 96.63% 89.55% 
5 99.21% 96.02% 94.38% 83.06% 
10 95.91% 89.48% 86.83% 74.50% 
Letter E 
 
5 250 
0.5 100% 99.00% 97.75% 84.82% 
1 100% 98.62% 97.22% 84.31% 
2 99.96% 97.20% 95.51% 81.76% 
3 99.58% 96.38% 94.33% 82.47% 
5 98.31% 93.78% 92.13% 79.18% 
10 96.14% 90.63% 88.00% 73.74% 
Diamond 
Shape 
 
5 250 
0.5 98.71% 93.54% 90.65% 78.64% 
1 97.95% 93.37% 89.85% 76.92% 
2 96.92% 92.24% 89.14% 76.95% 
3 96.15% 92.04% 89.30% 78.41% 
5 95.91% 90.72% 87.78% 76.01% 
10 91.82% 85.76% 81.88% 68.16% 
Random 
Shape 
 
5 250 
0.5 100% 99.12% 98.05% 84.77% 
1 100% 99% 98.8% 84.95% 
2 99.88% 98.32% 96.19% 82.43% 
3 99.30% 96.42% 94.33% 81.35% 
5 97.75% 94.26% 91.85% 78.84% 
10 92.60% 85.70% 82.26% 67.56% 
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Table 4 presents the Monte Carlo dose calculation time at different variances. The 
table shows a huge increase in the calculation time as the uncertainty is reduced. 
The calculation time appears to increase exponentially as the variance is reduced.  
 
Table 4 Calculation times for square fields at different variances 
 
 
Figure 7 shows calculation time plotted against variance for some field size which 
shows that the time increase with reduction in variance does indeed appear to be 
exponential. The calculation time increased as the variance is reduced and as the 
field size is increased. 
 Calculation time (s) 
Variance (%) 2cm2 3cm2 5cm2 7cm2 10cm2 15cm2 20cm2 
0.5 % 41,5 69 163 306 621 1363 2412 
1 % 25,7 34 57 94 174 368 632,5 
2 % 22,5 25 31,5 39,5 62,2 119 192 
3 % 21,5 23,5 25,5 31 40,5 71,5 113 
5 % 20 22,5 23,5 25 30,7 47.5 69 
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Figure 7: Plot showing Monte Carlo calculation time as a function of variance and 
field size 
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3.2 Dosimetric effect of variance on DVH – IMRT clinical cases 
 
Figures 8 and 9 are used to show the effect of using different variance when 
computing the dose distribution in a patient. Considering figure 8, the calculation 
made with a variance of 10 % appears to agree more with that made with a 
variance of 0.5 % (assumed to be the most correct), than the calculation made with 
a variance of 5 %. In the region of the dose to about 10 % of the structures (high 
dose region), the effect of varying variance seems to be most evident with about 
1000 cGy difference in the dose to the structure in this region being projected with 
the dose calculations made with variance of 0.5, 1 and 3 % and that made with a 
variance of 5 %. 
 
Figure 8 shows the effect of using different variance in computing the dose on the 
dose volume histogram (DVH) of a patient (case 1) 
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Considering figure 9, if the DVH computed with a variance of 0.5 % is assumed to 
be the most accurate, then the observed pattern is mostly in agreement with the 
expectation since that made with a variance of 10 % deviated the most from this 
value as is expected, and that computed with a variance of 1 % is probably the 
second most accurate (again, assuming that that made with a variance of 0.5 % will 
agree more with the measured. No measurements were made in the case of the 
patient dose calculation data. 
 
 
Figure 9: shows the effect of using different variance in computing the dose on the 
DVH of a patient (case 2). 
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4. Discussion 
 
Table 3 shows the dose calculation time for a square 10 X 10 cm field while tables 
1 and 2 show the gamma evaluation results. From table 1, it can be seen that the 
gamma evaluation results for the calculations made with variances of 0.5 and 1 % 
are quite similar. Table 3 however show the dose calculation time with a variance 
of 0.5% is more than 3 times the time required for dose calculation with an 
uncertainty of 1%. It can thus be concluded that there is no significant gain in 
going lower than a variance of 1% since there is no significant improvement in the 
accuracy of the calculated dose when compared with the measured. Figure 7, 
which is a plot of the computation time against variance show that it will be 
impossible to achieve a Monte Carlo calculation dose distribution calculation of 
absolute accuracy, i.e. one with no variance. This is so because as the plots clearly 
show, as the variance tends to zero, the computation time tends to infinity. 
The recommended upper and lower values for variance to be used for calculation 
of dose distribution are 3 % and 1 % respectively. The findings of this research 
also agrees with the suggestion since at higher variances, the result of the gamma 
result is decreased due to increase failure of agreement between the calculated 
and the measured dose distribution. The results of this research is in agreement 
with the recommended variance values of 1% to 3% since the range of values 
appear to be very  good compromise between reducing calculation time and 
having an accurate calculation of dose distribution. Based on the gamma result, at 
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DD of 4% and DTA of 3 mm, there is agreement between the calculated and 
measured dose distribution in almost all the cases. This value is also the 
recommended value that is used in clinical routine for IMRT quality assurance. The 
purpose of the dose computation in the first place is to accurately determine the 
dose that will be deposited in the patient from the beam geometry employed for 
the treatment. To simulate the dosimetric impact due to the use of different 
variance values in the dose computation, patient dose was computed for IMRT 
cases using different variance values. The results showed substantial difference 
between the plans made with the different variances (Figures 8 and 9). Dose 
computed with variances of 1 and 10 % for a subject showed up to 1000 cGy 
difference in the dose to 90 % of the structure’s volume, while the dose calculated 
with variance of 0.5 and 5 % for another subject showed up to 1000 cGy difference 
in the dose to approximately 10 % volume of the structure. Such large variation 
could lead to adverse effects (Indrin et. al., 2007).. 
The results also show that at small field sizes, the calculated and measured dose 
distribution always agrees irrespective of the variance values used. In other words, 
for small field size, even when high values of variance were used during the dose 
calculation, the gamma evaluation passed. Thus for a small field, large 
uncertainties in calculation still yielded accurate result. This means that when the 
field is small, the large variances can be employed to reduce the calculation time. 
At DD and DTA of 5% and 5 mm respectively, the evaluation result is nearly passed 
in all the cases. However, this is not a good evaluation criterion since the pass 
criterion is fairly loose and a dose difference value of 5% between the calculated 
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and predicted is substantial. Lower values such as the 4% and 3 mm values 
commonly employed in QA programs are more stringent criteria that should be 
used. 
A unique pattern is observed for the gamma evaluation result of the rectangular 
field (Table 2). The 10 x 2 cm and 2 x 10 cm field sizes are of the same dimension; 
however both shapes are defined by different number of MLC leaf pairs that has to 
be in the open position during the irradiation of the film. For the 10 x 2 cm field 
size, only2 leaf pairs are open, whereas the 2 x 10 cm fields requires 10 MLC leaf 
pairs to be in the open position ( leaf width = 1 cm). The 10 x 2 cm field will be 
referred to as the horizontally oriented field and the 2 x 10 cm field will be 
referred to as the vertically oriented field. Both field dimensions will be referred to 
as case a. The same convention will be used in describing the 15 x 5 cm and 5 x 15 
cm fields, i.e. 15 x 5 cm field being horizontally oriented and 5 x 15 cm field being 
vertically oriented. Both fields will be referred to as case b. It was observed that 
the gamma results for the vertically oriented field was better than that of the 
horizontally oriented field for all observations in case a, with a reversal of the 
pattern in case b, i.e. the horizontally oriented field having more pass values than 
the vertically oriented one. The reason for such discrepancies and reversal of 
pattern is not easily understandable. This observation is however, not statistical 
since this pattern was true for all 40 comparison points made for the two field 
sizes. 
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The results of this research are also mostly in agreement with results reported by 
earlier researchers. At a variance of 3 % and gamma evaluation criteria of 3 % and 
3 mm for the DD and DTA respectively, the results are mostly similar with that 
reported by Wang (Wang et al., 1996). However, with an increase in the acceptable 
variance in dose calculation to 5 %, the result agree more with that reported in the 
work of Ma (Ma et al., 2000, Oldham and Webb, 1997). From the results, it can thus 
be possible to predict the calculation time (for a square field in this case) for any 
given field size and variance with fair degree of accuracy with increase with 
increasing field size. Since the data shows calculated time to tend more towards 
agreeing with the modeling function as the field size increases. The results also 
show that the calculation times tend to infinity as the variance approaches zero.  
 
 
 
 
 
 
 
 
36 
 
 
5. Conclusion 
 
In conclusion, the result of this work showed the Monte Carlo method to achieve 
good dose calculation results. The results are similar to that reported in previous 
literature. However, the accuracy of the dose calculation comes at the expense of 
computation time whose increase appears exponential with increasing dose 
calculation accuracy. The dosimetric effect of using different variances on the DVH 
pattern was studied and the result showed substantial dose difference between 
dose computations made with low and high variances. This huge dose difference 
due to variance selection could result in serious therapeutic consequences. 
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